O-linked protein glycosylation is a conserved feature of the Burkholderia genus. For Burkholderia cenocepacia, the addition of the trisaccharide β-Gal-(1,3)-α-GalNAc-(1,3)-β-GalNAc to membrane exported proteins is required for virulence and resistance to environmental stress. However, the underlying causes of the defects observed in the absence of glycosylation are unclear. This study demonstrates that the global B. cenocepacia proteome undergoes dramatic changes consistent with alterations in global transcriptional regulation in the absence of glycosylation. Using luciferase reporter assays and DNA cross-linking analysis, we confirm the repression of the master quorum sensing regulon CepR/I in response to the loss of glycosylation, which leads to the abolition of biofilm formation, defects in siderophore production, and reduced virulence. The abundance of most of the known glycosylated proteins did not significantly change in the glycosylation-defective mutants except for BCAL1086 and BCAL2974, which were found in reduced amount, suggesting they could be degraded.
Introduction
The Burkholderia cepacia complex (Bcc) includes diverse and ubiquitous, phylogenetically related Gram-negative species (1) . To-date, 20 Bcc species have been identified (1) (2) (3) , but the commonality of Bcc in the environment (2, 3) and their recognition as opportunistic pathogens (4) (5) (6) continually drives the identification of new Bcc members. Within clinical settings Bcc can lead to fatal infections (7, 8) which are both challenging to control with antibiotic therapies (9) and can be spread by patient-to-patient transmission (10, 11) . This is especially problematic for Bcc infections within cystic fibrosis (CF) patients, where Bcc infections result in accelerated loss of lung function (12) as well as increased morbidity and mortality compared to other infectious agents (13, 14) . B. cenocepacia is one of the most common Bcc species isolated from CF patients across the globe (15) (16) (17) (18) and is generally associated with more fulminant disease leading to higher mortality than observed with other Bcc species (19) . One of the most serious clinical outcomes from B. cenocepacia infections in CF patients is a condition known as 'cepacia syndrome', an unrelenting necrotizing pneumonia that rapidly leads to respiratory failure, bacteraemia and death (20) . Although interventions with antimicrobial therapies can stop or even reverse cepacia syndrome (20) , the intrinsic resistance of Bcc to multiple classes of antibiotic (21) (22) (23) and their propensity to form biofilms (24) makes treatment success variable at best (9) . It is therefore essential to better understand factors involved in B. cenocepacia virulence in order to improve clinical outcomes.
The ability to form biofilms is associated with bacterial persistence and the failure of antimicrobial treatments in a range of pathogens (25) . Bcc members, including B. cenocepacia, produce biofilms on abiotic (26, 27) and biotic surfaces (28) . However, B. cenocepacia in the CF lung do not appear to form true biofilms, but instead are observed extracellularly as small clusters surrounded by mucus, or in phagocytic cells in the submucosal tissue (29, 30) . Increased biofilm production is associated with bacterial persistence in CF patients (31) and mutations selected for during chronic infections in CF patients mirror those observed during biofilm directed evolution experiments (32) . The ability to form biofilms in Bcc, as well as the expression of multiple virulence factors, is controlled by numerous quorum sensing (QS) systems (33) . A key class of QS systems associated with Bcc virulence are based on homoserine lactones (HSL) (24) . Across the Bcc, some HSL QS systems are variable or lineage-specific, such as cciR/I and CepR2 (34, 35) , while others are highly conserved in all members. One such highly conserved HSL QS system is the CepR/I regulon (36, 37) , which generates N-octanoylhomoserine lactone (C8-HSL) using the HSL synthase CepI that in turns activates the transcriptional regulator CepR (37, 38) . CepR is a major regulator of biofilm formation (39) , and disruption of CepR/I attenuate Bcc virulence in several models (40, 41) and reduces disease severity (40, 42) . The importance of the CepR/I QS system in Bcc virulence stems from its broad regulatory profile affecting multiple virulenceassociated genes (43) (44) (45) such as those encoding the secreted zinc metalloproteases ZmpA (46) and ZmpB (47) , siderophore production (39, 48) and the key mediator of Biofilm formation protein A (BapA) (45) .
Glycosylation is increasingly recognised as a common modification in bacterial systems (49) (50) (51) (52) (53) (54) (55) (56) . Many glycosylation systems are conserved across bacterial genera (57, 58) and phyla (59, 60) , suggesting glycosylation is critical for optimal proteome functionality. Disruption of glycosylation pathways in several species results in reduced fitness compared to glycosylation competent strains (52) (53) (54) (55) (56) . However, the underlying cause of the reduction in fitness remains poorly defined (61, 62) . Only recently have mechanistic insights emerged on how the loss of glycosylation affects bacterial physiology and pathogenesis. In Campylobacter jejuni, the loss of glycosylation results in decreased stability of the majority of known glycoproteins, which in turn affects virulence (63, 64) . These data support a model whereby bacterial N-linked glycosylation contributes to protein stability, but it is unclear whether other glycosylation systems, such as O-linked glycosylation, have evolved to stabilize glycosylated proteins.
Previously, we reported B. cenocepacia possesses an O-linked glycosylation system responsible for the modification of at least 23 proteins with a trisaccharide glycan using the enzyme PglL (BCAL0960) (56) . Building on this work we recently identified the biosynthetic locus, the O-glycosylation cluster (OGC, BCAL3114 to BCAL3118) responsible for the generation of the O-linked glycan, established the O-linked glycan structure as β-Gal-(1,3)-α-GalNAc-(1,3)-β-GalNAc, and demonstrated that glycosylation was required for optimal bacterial fitness and resistance to clearance in Galleria mellonella infection models (65) .
Although these studies have demonstrated a link between glycosylation and virulence, the mechanism remains unclear. Using quantitative proteomic approaches, we sought to understand the proteome changes resulting from the loss of O-linked glycosylation in B.
cenocepacia. We demonstrated that loss of glycosylation in B. cenocepacia resulted in global proteome alterations beyond the known glycoproteome, which are associated with widespread alterations in transcriptional regulation. We discovered that the HSL QS system CepR/I is repressed in glycosylation-defective mutants, which leads to defective biofilm formation and reduced siderophore production. In contrast to the loss of glycosylation in C. jejuni, we also demonstrate that only a few glycoproteins are reduced in abundance in the absence of glycosylation, but they are not responsible for the glycosylation-null phenotypes. Together, our data indicate that the roles of glycosylation in B. cenocepacia extend beyond protein stabilisation, and loss of O-linked glycosylation in B. cenocepacia causes dramatic physiological changes by altering the global regulatory CepR/I QS system.
Methods

Bacterial strains and growth conditions:
Strains and plasmids used in this study are listed in Supplementary Table 1 mM NaCl and 0.1% Tween 20) and then incubated for at least 16 hours at 4°C with either mouse monoclonal anti-His (1:2,000; AD1.1.10, AbD Serotech) or mouse anti-RNA pol (1:5,000; 4RA2, Neoclone). Proteins were detected using anti-mouse IgG horseradish peroxidase (HRP)-conjugated secondary antibodies (1:3,000; catalog number NEF822001EA, Perkin-Elmer) and developed with Clarity Western ECL Substrate (BioRad).
All antibodies were diluted in TBS-T with 1% bovine serum albumin (BSA; Sigma-Aldrich).
Images were obtained using an MFChemiBis imaging station (DNR Bio-Imaging Systems) or an Amersham imager 600 (GE life sciences).
Whole cell lysis of bacterial samples. Bacteria were grown overnight on LB plates.
Plates were flooded with 5 ml of pre-chilled sterile phosphate-buffered saline (PBS) and colonies removed with a cell scraper. Cells were washed 3 times in PBS and collected by centrifugation at 10,000 x g at 4˚C then snap frozen. Frozen whole cell samples were resuspended in 4% SDS, 100 mM Tris pH 8.0, 20 mM DTT and boiled at 95˚C with shaking at 2000 rpm for 10 minutes. Samples were then clarified by centrifugation at 17,000 x g for 10 minutes, the supernatant collected, and protein concentration determined by bicinchoninic acid assay (Thermo Scientific Pierce). 200 μg of protein from each sample was acetone precipitated by mixing 4 volumes of ice-cold acetone with one volume of sample. Samples were precipitated overnight at -20˚C and then centrifuged at 16,000 x g for 10 minutes at 0˚C.
The precipitated protein pellets were then resuspended in 80% ice-cold acetone and precipitated at -20˚C. for an additional 4 hours. Samples were spun down at 17,000 x g for 10 minutes at 0˚C to collect precipitated protein, the supernatant discarded, and excess acetone evaporated at 65˚C for 5 minutes. Samples were precipitated overnight at -20˚C and then spun down at 16,000 x g for 10 minutes at 0˚C. The precipitated protein pellets were precipitated with 80% ice-cold acetone and resuspended as indicated above. (72) . Peptidomic samples were isolated according to Parker et al (73) . Briefly, guanidinium chloride lysis buffer solubilised lysates were precipitated with 20% trichloroacetic acid on ice for 3 hours, then sample were centrifuged at 10,000 x g for 10 minutes at 0˚C, the resulting supernatant collected and peptide isolated with tC18 columns (Waters). Bound peptides were eluted with 50% acetonitrile (ACN), 0.1% FA, dried and stored at -20˚C. Supplementary Table 4 . BCAL3530, BCAL0462, BCAM0904 were included as positive controls to ensure equal DNA enrichment while CepI is a non-DNA binding control. Data-independent acquisition was performed by switching between the acquisition of a single Orbitrap MS scan (70,000 resolution, m/z 350-1400) and HCD MS/MS events of each PRM precursor (maximum fill time 110ms, AGC 2 x 10 5 with a resolution of 35,000 for Orbitrap MS-MS scans, see Supplementary Table 4 for further details).
Digestion
Peptidomic analysis was undertaken on an Orbitrap Elite™ with 120 minute gradients run altering the buffer composition from 1% buffer B to 28% B over 90 minutes, then from 28% B to 40% B over 10 minutes, then from 40% B to 100% B over 2 minutes, the composition was held at 100% B for 3 minutes, and then dropped to 3% B over 5 minutes and held at 3% B for another 10 minutes. The Elite™ Mass Spectrometer was operated in a data-dependent mode automatically switching between the acquisition of a single Orbitrap MS scan (60, Table 6 ). CepR regulated proteins were defined as those proteins which were previously reported by O'Grady et al as differential regulated in K56-2 cepR at stationary phase (43) . Proteomics data sets have been deposited to the ProteomeXchange Consortium via the PRIDE (84) partner repository with the dataset identifier PXD014429, PXD014516, PXD014581, PXD014614 and PXD014700. For a complete description of each PRIDE dataset see Supplementary Table 5 .
Motility assays. Motility assays were conducted using semi-solid motility agar consisting of LB infusion medium supplemented with 0.3 % agar as previously described (56) .
Plates were inoculated using 2 μl of standardized, OD600 of 0.5, overnight cultures of each strain. Motility zones were measured after 48 hour incubation at 37°C. Experiments were carried out in triplicate with 3 biological replicates of each strain.
Transcriptional Analysis by luminescence assays. To assess transcriptional changes in CepR and CepI luxCDABE reporter assays were performed using B. cenocepacia K56-2 wild-type (WT), ∆pglL, ∆OGC and ∆pglL amrAB::S7-pglL-his10 strains containing pCP300 (CepI promoter luxCDABE reporter (85)), pPromcepR (CepR promoter luxCDABE reporter (86)) or pMS402 (promoterless luxCDABE reporter (87)) as a negative control.
Overnight cultures were diluted to an OD600 of 1.0 and 2 l inoculated into 200 l LB supplemented with 100 μg/ml trimethoprim in black, clear-bottomed 96-well microplates (minimum of eight technical replicates per independent biological replicate). The OD600 and relative luminescence were measured using a CLARIOstar plate reader at 10-minute intervals for 24 hours. Experiments assessing the effect of C8-HSL additions on CepR and CepI transcription were performed according to Le Guillouzer et al (88) . Briefly, cultures were supplemented with C8-HSL (Sigma-Aldrich) resuspended in acetonitrile (10 µM final concentration) and added to cultures with acetonitrile added alone used as a negative control.
Plates were incubated at 37°C with shaking at 200 rpm between measurements with each assay undertaken 3 independent times on separate days. The resulting outputs were visualised using R (https://www.r-project.org/). CAS siderophores assays. Alterations in production of siderophores was assessed using Chrome Azurol S (CAS) assay as previously described (93, 94) . 10 μl of OD600 1.0 adjusted bacterial culture were spotted on CAS agar plates and incubated at 37°C for 24 hours. The diameter of the zone of discoloration from the removal of iron from the CAS dye complex was measured. Experiments were carried out in technical triplicate with 3 biological replicates.
Proteases activity-based probes. K56-2 WT, ∆pglL and ∆pglL amrAB::S7-pglL-his10 strains were grown overnight on confluent LB plates. Plates were flooded with 5 ml of prechilled sterile PBS and colonies removed with a cell scraper. Cells were washed 3 times in chilled PBS and resuspend in 40 mM Tris, 150 mM NaCl pH 7.8 then lysed by sonication.
Samples were clarified by centrifugation, 10,000 x g, 10 minutes at 4°C and samples were diluted to a total concentration of 4 mg/ml. Reactivity to three classes of activity-based probes were assessed using PK-DPP (Cy5-tagged probe for Trypsin-like proteases (95)), PK105b (Cy5-tagged probe for Elastase-like proteases (96)), PK101 (Biotin-tagged probe for Elastaselike proteases (97)) and FP-Biotin (Biotin-tagged probe for Serine hydrolases (98)) which were added at 1.3 µM from a 100x DMSO stock. Untreated control samples were prepared in parallel and left untreated to allow the assessment of autofluorescence and endogenous biotinylation in lysates. Samples were incubated at 37˚C for 15 minutes to allow labelling and then quenched by the addition of Laemmli Sample Buffer. Samples were then boiled and proteins were resolved on a 15% SDS-PAGE gel. For Cy5-tagged probes, labelling was detected by directly scanning the gel for Cy5 fluorescence using a Typhoon 5 flatbed laser scanner (GE Healthcare). For FP-Biotin, proteins were transferred to nitrocellulose and the membrane was incubated with streptavidin-AlexaFluor647 at 4˚C overnight. Following three washes with PBS containing 0.05% Tween 20, the membrane was scanned on the Typhoon 5 in the Cy5 channel. Experiments were carried out in biological triplicate. All probes were synthesised in house by the Edgington-Mitchell Laboratory according to published methods, with the exception of FP-Biotin, which was purchased from Santa Cruz Biotechnology.
Results
Loss of glycosylation in B. cenocepacia leads to global proteome alterations.
We previously demonstrated that loss of glycosylation causes defects in motility (56) , reduction of virulence in plant and insect infection models (56, 65) , and defects in carbon utilisation (65) . To better understand the role of glycosylation in B. cenocepacia we assessed the effect of loss of glycosylation on the proteome. To achieve this we generated markerless deletion mutants in the O-oligosaccharyltransferase pglL (∆pglL; BCAL0960 (56)) gene, the recently identified O-linked glycan cluster (∆OGC; BCAL3114 to BCAL3118) responsible for the generation of the glycan used for O-linked glycosylation (65) , and a double glycosylation null strain (∆pglL∆OGC). We also constructed a chromosomal pglL complemented strain (∆pglL amrAB::S7-pglL-his10, Supplementary Figure 1A) . The rationale for creating multiple glycosylation-defective strains was to eliminate potential confounding effects arising from blocking glycosylation at a specific step and the corresponding accumulation of unprocessed lipid-linked glycans. Western blot analysis using the glycoprotein acceptor protein DsbANm-his6 (56, 99) confirmed the loss of glycosylation in ∆pglL, ∆OGC, and ∆pglL∆OGC, as well as restoration of glycosylation in ∆pglL amrAB::S7-pglL-his10 ( Figure 1A) . In contrast to our previously reported plasmid based PglL complementation approaches (56) chromosomal complementation lead to the restoration of glycosylation to near wild-type levels (Supplementary Figure 1B) as well as restoration of motility (Supplementary Figure 1C) compared to only partial restoration previously reported (56) .
Using label-free based quantitative proteomics, 5 biological replicates of each strain were investigated leading to the identification of 3399 proteins with 2759 proteins quantified in at least 3 biological replicates in a single biological group ( Supplementary Figure 2 , Supplementary Table 7 ). Hierarchical clustering of Pearson correlations of proteome samples demonstrated robust correlation between all samples (Average Pearson correlation of 0.98, Supplementary table 8) yet three discrete proteome clusters were readily identified separating the wild-type K56-2, ∆pglL amrAB::S7-pglL-his10 strains and glycosylation-null strains ( Figure  1B ). Examination of the most profound alterations, proteins with -log10(p)>3 and a fold change greater than +/-2 log2 units, revealed alterations in protein levels observed in ∆pglL that were mirrored in strains ∆OGC and ∆pglL∆OGC, which were restored by complementation ( Figure   1C ). Consistent with the observed motility defects (Supplementary Figure 1C) , the levels of proteins associated with flagella-mediated motility and chemotaxis, including BCAL0114 (FliC), BCAL0129 (CheA), BCAL0524 (FliG) and BCAL0525 (FliF), were significantly reduced in glycosylation-null strains. Importantly, multiple known virulence-associated proteins were also decreased in the glycosylation-null strains including the heme receptor protein BCAM2626 (HuvA (100)) and nematocidal protein BCAS0293 (AidA (101)). Numeration of the overlap of all altered protein between glycosylation-null strains by Fisher exact enrichment analysis demonstrated a substantial enrichment between these three groups (Fisher exact test: 6.7502 x 10 177 and 4.3784 x 10 245 for ∆pglL compared with ∆OGC, and for ∆pglL compared with ∆pglL∆OGC, respectively, Supplementary Table 9 , Supplementary Figure 3) .
These results revealed that the loss of glycosylation due to disruption of pglL or OGC leads to similar changes, which are largely complemented to parental levels by reintroduction of pglL in the chromosome. Supplementary Table 9 ). Interestingly, enrichment analysis highlighted the link between the loss of O-linked glycosylation and changes that were broader than only motility and virulence. For example, differences also observed in proteins associated with DNAsequence specific binding and transcriptional regulation (Figure 2 , Supplementary Table 9 ). This observation suggested that the loss of glycosylation results in alterations in the transcriptional landscape of B. cenocepacia. As virulence is coordinated by global regulators such as CciR, CepR, ShvR and AtsR in B. cenocepacia (35, 43, 86, 102) , we assessed if known regulators could account for the observed proteome changes in glycosylation-null strains. As our data demonstrated minimal alteration of the regulator ShvR (BCAS0225, Supplementary Table 7 ) across the analysed strains, and disruption of both atsR (BCAM0379) and cciR (BCAM0240) has previously been associated with increased motility (43, 86) , we reasoned that the regulator CepR may be responsible for the glycosylation-dependent differences in our mutant strains. This would be consistent with the observed decrease in BCAS0293 (AidA, Figure 1C ) which is stringently regulated by CepR (45, 103) . Using available microarray data of CepR-regulated genes (43), we investigated the correlation of the proteome changes observed in the absence of glycosylation, with alterations observed in response to the disruption of CepR. We observed a statistically significant enrichment of CepR-regulated proteins altered in the absence of glycosylation (multiple hypothesis corrected p-value 1.79 x 10 6 and 6.69 x 10 6 for ∆pglL and ∆OGC respectively, Supplementary table 9 ), supporting a link between CepR and the alteration observed in glycosylation-null strains and suggesting that the loss of glycosylation may influence the B. cenocepacia CepR regulon.
Loss of glycosylation results in reduced CepR/I transcription and the levels of
To determine transcriptional changes in cepR/I genes we introduced the cepR and cepI luciferase promoter reporter (pPromcepR (86) and pCP300 (85) Figure 5) . As the C8-HSL levels affect the response of CepI and CepR in B. cenocepacia (39, 44, 104) , we assayed cepR/I transcription in the absence and presence of additional C8-HSL (10 M, Figure 3B ). In response to exogenous C8-HSL, cepI transcription increased in all strains ( Figure 3B) , consistent with the positive feedback response expected to heighten C8-HSL levels (39, 44) . In contrast, while the addition of C8-HSL led to no change in cepR transcription in ∆pglL, it resulted in reduced transcription of cepR to the level observed in the wild type K56-2. As expected from the reduction in cepR/I transcription resulting from the loss of glycosylation, cepR and cepI transcription was also compromised in ∆OGC strains ( Supplementary Figure 6 and 7) . Together, these results indicate that both cepR and cepI transcription are altered in the loss of glycosylation, with the resulting cepR levels resembling the levels observed during C8-HSL-induced repression in wild type.
As the CepR protein autoregulates cepR's own transcription (48) , we reasoned that the decreased transcription in ∆pglL would correspond to decreased levels of DNA bound CepR.
To directly assay DNA binding by CepR, we monitored the DNA bound proteome using formaldehyde-based cross-linking coupled to DNA enrichment (105) . Initial analysis of the DNA-bound proteome found glycosylation-null strains (∆pglL and ∆OGC) and glycosylationproficient strains (wild type and ∆pglL armAB::S7-pglL-his10) possessed distinct proteome profiles with multiple uncharacterised transcriptional regulators (e.g. BCAL0946, BCAL1916, BCAS0168, BCAL2309 and BCAL0472) which were altered by the loss of glycosylation ( Figure 3C , Supplementary Table 10 ). Although this analysis enabled the identification of CepR, its low abundance prevented its quantitation across biological replicates. To improve the monitoring of CepR, targeted proteomic analysis was undertakening using PRM assays confirming the reduction in DNA associated CepR in ∆pglL compared with wild type and ∆pglL armAB::S7-pglL-his10 ( Figure 3D , p-value= 0.017 wild type vs ∆pglL, Supplementary Table   11 ). In agreement with the total proteome and lux reporter measurements, the DNA-bound proteome supports multiple transcription associated proteins, including the global regulator CepR, that are altered in the absence of glycosylation. ∆pglL demonstrates a reduced ability to form biofilms and produce siderophores. The observed reductions in CepR/I transcription suggested that CepR/I-linked regulation may also be altered in glycosylation-null strains. To test this hypothesis, we assessed two phenotypes associated with CepR/I regulation, the production of biofilm under static 24-hour growth and siderophore production (39, (43) (44) (45) 48) . Consistent with an impact of glycosylation on CepR/I-mediated regulation, we observed a profound reduction in biofilm formation in ∆pglL, which was partially restored by complementation ( Figure 4A) . Interestingly, we observed that the method of complementation, i.e. expression of PglL-his10 driven from the native pglL promoter (∆pglL amrAB::native-pglL-his10) or from the constitutive S7 promoter (∆pglL amrAB::S7-pglL-his10) impacted the restoration of biofilm formation ( Figure 4A ).
Examination of independently created ∆pglL and ∆pglL amrAB::native-pglL-his10 strains confirmed a link between biofilm formation, through phenotype restoration following complementation ( Supplementary Figure 8) . CAS assays, used to assess the global levels of siderophore activity, demonstrated a modest but reproducible effect in ∆pglL which was completely restored by complementation when PglL was expressed from either the native or S7 promoter ( Figure 4B and C) . Together, these findings support the notion that CepR/I regulate multiple phenotypes including biofilm and siderophore production, which are affected by the loss of glycosylation.
Except for BCAL1086 and BCAL2974, proteins that are normally glycosylated remain stable in the absence of glycosylation. As the loss of glycosylation in other bacterial glycosylation systems leads to protein instability (63, 64, 106), we examined whether protein instability in B. cenocepacia may be responsible for the phenotypic changes in glycosylationnull strains. Our proteomic analysis identified 21 out of 23 known glycoproteins (56), yet only 2 were altered in abundance in glycosylation-negative strains; BCAL1086 (-5.7 log2) and BCAL2974 (-2.5 log2) ( Figure 5A, Supplementary Table 7) . To confirm the observed decreases in abundance, endogenous BCAL1086 and BCAL2974 were his10-tagged at the C'-terminus. While his-tagging did not allow the detection of BCAL2974 by western analysis (data not shown), the introduction of the his10 epitope into BCAL1086 allowed quantification of endogenous BCAL1086 in the K56-2 wild-type, ∆pglL and ∆pglL amrAB::S7-pglL-his10 backgrounds and confirmed the loss of BCAL1086 in ∆pglL ( Figure 5B ). We sought to directly assess whether BCAL1086 was subjected to increased degradation in ∆pglL, as a measure of instability. For this, we monitored the endogenous peptide pool (73) quantifying peptides derived from 783 proteins ( Supplementary Table 12 and 13) in B. cenocepacia K56-2 WT, ∆pglL and ∆pglL amrAB::S7-pglL-his10 strains. Consistent with the degradation of BCAL1086 we observed an increase in the abundance of BCAL1086-derived peptides in ∆pglL while peptides from other known glycoproteins showed only modest changes ( Figure 5C , Supplementary Table 13 ). Within this peptidomic analysis, we observed that multiple unique BCAL1086 peptides are were present in ∆pglL clustered around the central region of BCAL1086 ( Figure 5D ), confirming that BCAL1086 was expressed in ∆pglL but was subject to proteolysis. Together, our data support that BCAL1086 becomes degraded in the absence of glycosylation, but the majority of known B. cenocepacia glycoproteins are unaffected.
Role of BCAL1086 and BCAL2974 in ∆pglL phenotypes. As changes in the glycoproteins BCAL2974 and BCAL1086 coincided with an alteration in CepR/I activity, we investigated if the loss of BCAL2974 and BCAL1086 could be responsible for defects observed in ∆pglL. To answer this question, ∆BCAL2974 and ∆BCAL1086 strains were created and assessed for their effect on biofilm and siderophore production as well as virulence in G. mellonella, a phenotype previously associated with ∆pglL (56). Assessment of 24-hour static biofilm growth showed ∆BCAL1086 had no effect on biofilm formation while ∆BCAL2974 resulted in a small but consistent decrease in biofilm development. However, this effect is minimal compared to the defect observed in ∆pglL and ∆cepI ( Figure 6A ). The ability of ∆BCAL1086 and ∆BCAL2974 to produce siderophores was unaffected ( Figure 6B and C) .
Similarly, while G. mellonella infections showed that ∆pglL causes reduced mortality at 48 hours post infection compared to K56-2 WT, (p-value 0.0015), ∆BCAL2974, ∆BCAL1086 and ∆pglL amrAB::native-pglL-his10 strains resulted in wild type levels of lethality in G. mellonella at 48 hours ( Figure 6D ). These results suggest that even though BCAL2974 and BCAL1086 are influenced by the loss of glycosylation, neither protein is solely responsible for the known defect observed in ∆pglL.
We also investigated whether the loss of either BCAL2974 or BCAL1086 drives proteome changes. Using label-free based quantitative proteomics we compared the proteomes of K56-2 WT, ∆BCAL2974, ∆BCAL1086, ∆pglL, ∆cepR, ∆cepI and ∆pglL amrAB::S7-pglL-his10 to assess the similarity between the proteomes as well as the specific proteins effected by the loss of these proteins. Proteomics analysis led to the identification of 3730 proteins with 2752 proteins quantified in at least 3 biological replicates in a single biological group (Supplementary Table 14 ). Clustering of the proteomic analysis revealed that ∆BCAL2974 and ∆BCAL1086 closely grouped with that of WT strains while, ∆pglL, ∆cepR, ∆cepI and ∆pglL amrAB::S7-pglL-his10 formed discrete clusters. This macro analysis indicated that mutations in BCAL2974 or BCAL1086 had a minimal effect on the proteome (Figure 7A , Supplementary   Table 15A and B). Consistent with this conclusion, analysis of the specific proteins that varied between the different strains demonstrated few proteome alterations in ∆BCAL2974 and ∆BCAL1086 compared with ∆pglL, ∆cepR and ∆cepI ( Figure 7B ) with cepR, cepI and pglL also demonstrating the expected similarility in their proteome changes (Fisher exact test ∆cepR vs ∆pglL, p-value 3.25 x 10 5 and ∆cepI vs ∆pglL, 6.95 x 10 4 , Supplementary Table 16 ).
Taken together the proteome analysis supports the contention that BCAL2974 and BCAL1086 have minimal effect on the proteome and are not responsible for the broad proteomic alterations observed in ∆pglL.
Discussion
Although glycosylation is a common protein modification in bacterial species (49) (50) (51) 107) our understanding of how this modification influences bacterial physiology and pathogenesis is unclear. Recent insights into how glycosylation impacts bacterial proteomes have been obtained through study of the archetypical N-linked glycosylation system of C. jejuni (108, 109 ), yet it is unclear whether these observations are generalizable to another glycosylation systems such as O-linked glycosylation systems. Studies on the role of N-linked glycosylation within C. jejuni have revealed that defects associated with the loss of glycosylation stem from the loss of glycoproteins (108, 109) suggesting that N-linked glycosylation extends protein longevity in C. jejuni. In contrast, we find here that loss of O-linked glycosylation in B.
cenocepacia has a more limited effect on the proteins targeted for glycosylation with only a subset of the known glycoproteins affected by the disruption of glycosylation ( Figure 5 ). Therefore, the defect associated with loss of glycosylation in B. cenocepacia cannot be merely explained by protein instability. Indeed, we demonstrate that loss of glycosylation leads to changes in the expression of non-glycosylated proteins regulated by the CepR/I regulon ( Figure 3 ), a global regulator of bacterial physiological changes including virulence and motility (39, 42, 48) . Also consistent with a defect in the CepR/I regulon, loss of glycosylation results in lack of biofilm formation and reduced siderophore production. Therefore, our findings uncover a previously unknown link between loss of glycosylation and the repression of the CepR/I QS system.
The observation that biofilm formation is reduced in pglL mirrors previous reports in
Acinetobacter baumannii (55) and C. jejuni (63) , but the link of this phenotype to alterations in regulations have not previously documented. Previous studies in B. cenocepacia have identified that not all CepR/I regulated proteins are required for biofilm formation. However, BapA (BCAM2143) plays a major role in the formation of biofilms on abiotic surfaces, whereas the lectin complex BclACB (BCAM0184-BCAM0186) contributes to biofilm structural development (45) . Although BapA (BCAM2143) was not detected by our proteomic analysis, BclA and BclB (BCAM0186 and BCAM0184 respectively) were observed and decreased in pglL (both -1.0 log2 decrease compared with WT, -log10(p): >3.05, Supplementary Table 7) . Surprisingly, BclA and BclB increased in abundance in pglLOGC and OGC strains (both 1.0 log2 increase compared with WT, -log10(p) >1.4, Supplementary Table 7) , and these mutants formed extensive biofilms ( Supplementary Figure 9 ). This result is consistent with recent work which has shown that with disruption of BCAL3116, the third gene in the OGC, resulted in enhanced biofilm formation (110) although the underlying mechanism driving this phenomenon is unclear. Concerning siderophore production, our proteomic data reveal that siderophore-associated proteins were reduced in both pglL and OGC (Figure 2 ) with glycosylation-null strains producing reduced zones of clearing in the CAS assays ( Figure 4B and C, Supplementary Figure 10 ). However, the magnitude of the reduction in the CAS assays differed in the mutant since OGC and pglLOGC presented significantly smaller zones of clearing than pglL ( Supplementary Figure 10) . These results highlight that although the proteome changes observed in the glycosylation mutants pglL and OGC are highly similar they are not identical and show phenotypic differences. Therefore, a key question arising from our findings is how the loss of glycosylation alters gene regulation and whether the observed defects are simply the result of altered CepR transcriptional control. The lack of any glycosylated QS-associated proteins in B. cenocepacia (56) makes the identification of the link between a specific glycoprotein and QS changes unclear.
It is possible the observed alterations in biofilm formation and siderophore production are not solely driven by altered CepR regulation, but also reflect additional transcriptional alterations in the glycosylation null strains. This conclusion agrees with our observations of many differences in the abundance of transcriptional regulators in the DNA-associated proteome of glycosylation null strains ( Figure 3C , Supplementary Table 10 ). An additional driver of these pleotropic effects may also be deleterious outcomes resulting from the manipulation of the Olinked glycosylation system. It has been suggested in C. jejuni that the disruption of glycosylation leads to undecaprenyl diphosphate decorated with N-linked glycan being sequestered from the general undecaprenyl diphosphate pool and that this depot effect may be a general phenomenon observed in all glycosylation mutants (64) . Sequestration of undecaprenyl diphosphate was thought to drive an increase in the abundance of proteins within the non-mevalonate and undecaprenyl diphosphate biosynthesis pathways observed in glycosylation-null C. jejuni (64) . However, in B. cenocepacia glycosylation mutants, we observe only minor alterations in the non-mevalonate (BCAL0802, BCAL1884, BCAL2015, BCAL2016, BCAL2085, BCAL2710, BCAM0911 and BCAM2738, Supplementary Figure 10A) and undecaprenyl diphosphate biosynthesis (BCAL2087 and BCAM2067, Supplementary Figure 10B ) pathways, which argues against this phenomenon being common to all glycosylation mutants. Furthermore, the similarity of the proteome changes in the pglL, OGC and pglLOGC strains ( Supplementary Figure 3 Another explanation for the pleiotropic effects associated with loss of O-glycosylation could be the instability of the glycoproteins in the absence of the glycan. We identified two glycoproteins BCAL2974 and BCAL1086, both of unknown functions, which are reduced in abundance due to the loss of glycosylation. However, genetic experiments demonstrate that neither protein is responsible for the phenotypic and proteomic changes associated with loss of glycosylation ( Figure 6 and 7) . Further, in the case of BCAL1086, endogenous tagging and degradomic analysis confirm the loss of this protein in the ∆pglL background. Although these results support the breakdown of BCAL1086 as a consequence of the loss of glycosylation, an alternative explanation is that the changes in degradation arise from alterations in protease levels or activities in the ∆pglL mutant. Previously, we reported that ∆pglL results in enhanced casein proteolytic activity (65) . However, our global proteome analysis shows only modest changes in protease levels. We also observed identical protease profiles from activity probe against multiple classes of protease in wild type, ∆pglL and ∆pglL amrAB::S7-pglL-his10
( Supplementary Figure 12 ), suggesting all of these strains have similar protease activities.
More importantly, aside of glycoproteins BCAL2974 and BCAL1086, the other proteins targeted for glycosylation remain consistently stable in the glycosylation-defective mutants.
Therefore, although loss of glycosylation may affect the stability of some glycoproteins, the pleiotropic effect found in the glycosylation mutants cannot be explained by alterations in protein degradation. 
